In a clinical trial of people with Type 2 diabetes and moderate to severe kidney disease, the drug reduced the risk of kidney ...
Novo Nordisk A/S is asking for more time to answer questions from US Senator Bernie Sanders on the prices of Ozempic and ...
Sen. Bernie Sanders, chair of the Senate Health, Education, Labor and Pensions Committee, has demanded to know why Americans ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
The U.S. Senate will investigate the price of Novo Nordisk's popular weight loss and diabetes drugs Ozempic and Wegovy. Sen. Bernie Sanders asked Novo Nordisk's CEO in a letter how the price of ...
TikTok users will not be allowed to upload “before-and-after” photos which are aimed at showing the affects of the ...
Ozempic seems like a wonder drug that's changing people's lives and could have profound effects on the entire economy. It also seems like it has generated at least a million dollars for David Paton.
Novo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says it is investing over $6 billion dollars to help meet the increased demand for the drugs amid ...
Three years ago injecting yourself skinny seemed positively futuristic. Now, everyone from Oprah Winfrey and Elon Musk to your local hairdresser are cashing in on Ozempic’s weight loss benefits.
Has Ozempic and its glucagon-like peptide 1 (GLP-1) next of kin found their place alongside Swiss army knives and jacks of all trades? A new report published by the Journal of American Medical ...
The Danish firm - controlled by the world's biggest charitable foundation - became Europe's biggest company by stock market ...
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.